GlobeNewswire
Adial Applauds Congressional Directive Advancing Alternative Clinical Trial Endpoints for Substance Use Disorders, Strengthening Regulatory Path for AD04
📈
AI Sentiment
Highly Positive
9/10
Adial Pharmaceuticals Inc News
Latest updates and market news for ADIL
2 news
Feb 3 - Feb 9, 2026
Page 1
GlobeNewswire
Adial Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Price Requirement
âž–
AI Sentiment
Neutral
4/10
Share this news page